Taking a Closer Look At Arcus Biosciences Inc (RCUS) Following Its Recent Trade
Arcus Biosciences Inc’s recent filing unveils that its Chief Financial Officer Goeltz II Robert C. unloaded Company’s shares for reported
Arcus Biosciences Inc’s recent filing unveils that its Chief Financial Officer Goeltz II Robert C. unloaded Company’s shares for reported
Arcus Biosciences Inc. (NYSE:RCUS) does about 1.18M shares in volume on a normal day but saw 853343 shares change hands
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.